Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2105-2021Class II

Cell Marque, RabMAb,CD17, c-kit (YR145) Rabbit Monoclonal Primary Antibody, REF: 117R-18, IVD, CE, GTIN...

Cell Marque Corp. / initiated 2021-05-27 / Terminated / root cause: manufacturing process

Cell Marque Corporation began a recall of Cell Marque, RabMAb,CD17, c-kit (YR145) Rabbit Monoclonal Primary Antibody, REF: 117R-18, IVD, CE, GTIN: 00841683123798 on . FDA classified it as Class II and gives the reason as "Product distributed for use as an In-vitro Diagnostics without FDA clearance". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-2105-2021
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Cell Marque Corp.
Product
Cell Marque, RabMAb,CD17, c-kit (YR145) Rabbit Monoclonal Primary Antibody, REF: 117R-18, IVD, CE, GTIN: 00841683123798
Product code
MVU Reagents, Specific, Analyte
Reason for recall
Product distributed for use as an In-vitro Diagnostics without FDA clearance
Root cause tag
manufacturing process
FDA root cause
Process control
Action
On May 27, 2021, Cell Marque Corporation issued a "Recall Notification" via e-mail to all affected consignee. On June 15, 2021 the firm issued a "Urgent Medical Device Recall Notification" to provide additional information. This communication was sent via e-mail. In addition to informing consignees about the recall, the firm asked customers to take the following actions: 1. Please immediately examine your inventory to determine if you have any remaining impacted product and forward a copy of this letter to the personnel in your organization that utilize this product and/or need to be made aware of this issue. 2.Cell Marque is requesting that you destroy any unused or partially used containers of the products and that you provide us with confirmation that the product has been destroyed. If you have already used all the products, please confirm that the product has been used and is no longer available. Please complete the Attachment 1 confirmation of receipt form and return to local contact indicated below. 3. In addition, if you may have further distributed the product, please identify your customers and notify them of this issue immediately. Your notification to customers should include a copy of this notification. 4. Technical Services: Toll free at 800.665.7284 | Press 1. Additionally, email us at [email protected] 5. Additionally, adverse reactions or quality problems experienced with the use of this product may be reported to the FDAs MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
Quantity in commerce
41 kits
Distribution
US: AL, AR, AZ, CA, FL, HI, ID, IL, KY, MN, MT, NC, NH, NY, PA, SC, VA, WI OUS: N/A
Product codes and lots
Lot Numbers: 0000058081/ Exp: 31 Dec 2021, 0000072580/ Exp: 30 Sep 2021, 0000090505/ Exp: 30 Sep 2022, 0000121052/ Exp: 31 May 2023

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2105-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2105-2021Class IITerminatedVoluntary: Firm initiated
Z-2106-2021Class IITerminatedVoluntary: Firm initiated